Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis
Syarifuddin E.
Asian Pacific Journal of Cancer Prevention
Q2Published: 2025
Abstract
The combination of oral capecitabine with varlitinib could be a promising second-line treatment for patients with advanced biliary tract cancer refractory to gemcitabine-based first-line regimen.
Access to Document
10.31557/APJCP.2025.26.8.2777Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
GemcitabineSciences
Biliary tract cancerSciences
Refractory (planetary science)Sciences
MedicineSciences
Line (geometry)Sciences
Second line treatmentSciences
ChemotherapySciences
OncologySciences
Biliary tractSciences
Meta-analysisSciences
Ideal (ethics)Sciences
Internal medicineSciences
MathematicsSciences
PhysicsSciences
AstrobiologySciences
PhilosophySciences
GeometrySciences
EpistemologySciences